PL
MYGN icon

Parkwood LLC’s Myriad Genetics MYGN Stock Holding History

Parkwood LLC’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-9,811
Closed -$368K – 472
2015
Q3 		$368K Hold
9,811
– – 0.06% 240
2015
Q2 		$333K Hold
9,811
– – 0.05% 264
2015
Q1 		$347K Sell
9,811
-567
-5% -$20.3K 0.04% 423
2014
Q4 		$353K Buy
+10,378
New +$368K 0.05% 368
2014
Q1 		– Sell
-7,700
Closed -$162K – 340
2013
Q4 		$162K Buy
+7,700
New +$195K 0.04% 299

Other funds holding MYGN

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Parkwood LLC's MYGN Position: Q4 2015 in Review

Parkwood LLC sold out of Myriad Genetics (MYGN) in Q4 2015, closing a stake of 9,811 shares — an estimated $368K sold.

Parkwood LLC first reported a position in MYGN in Q4 2013 and held it in 5 quarters. The position peaked at $368K in Q3 2015. 232 funds tracked by Wall St. Rank hold MYGN as of Q4 2015.

  • Parkwood LLC reported no remaining Myriad Genetics position as of Q4 2015 after selling out during the quarter.
  • Parkwood LLC sold 9,811 Myriad Genetics shares in Q4 2015, an estimated $368K.
  • Parkwood LLC first reported a position in Myriad Genetics in Q4 2013 and held it in 5 quarters.
  • Parkwood LLC's Myriad Genetics position peaked at $368K in Q3 2015.
  • 232 funds tracked by Wall St. Rank held Myriad Genetics as of Q4 2015.

Based on Parkwood LLC's 13F filing for Q4 2015, filed 4 Feb 2016.